Aditxt Inc. (ADTX) is a biotechnology company listed on NASDAQ.
Latest reported ADTX revenue for 2025-12-31 was $3.2K. Net income was -$43.1M. Revenue was down 97.6% from 2024-12-31 to 2025-12-31. ADTX currently screens at market cap $3.6K.
Use this ADTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ADTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ADTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Aditxt Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full ADTX income, balance, and cash tables.